Literature DB >> 24266358

Diagnosis of Clostridium difficile infection: the molecular approach.

Catherine Eckert1, Gabrielle Jones, Frédéric Barbut.   

Abstract

Diagnosis of Clostridium difficile infection is based on clinical presentation and laboratory tests. Although numerous laboratory methods are now available, the diagnosis of C. difficile infection remains challenging. Nucleic acid amplification tests (NAATs) are the most recent marketed methods. These methods detect genes for toxins A and/or B. They are very sensitive compared with the reference method (toxigenic culture) and are thus very promising, despite their cost. However, a positive NAAT result must be interpreted with caution owing to the possible detection of asymptomatic carriers of toxigenic strains who may have diarrhea for other reasons. The place of NAATs in current diagnostic strategies needs to be better defined, but the rapidity of the result is interesting for early recognition of the disease.

Entities:  

Mesh:

Year:  2013        PMID: 24266358     DOI: 10.2217/fmb.13.129

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  5 in total

Review 1.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

Review 2.  Sample-to-result molecular infectious disease assays: clinical implications, limitations and potential.

Authors:  Stacy G Beal; Naziheh Assarzadegan; Kenneth H Rand
Journal:  Expert Rev Mol Diagn       Date:  2016-01-11       Impact factor: 5.225

3.  Retrospective Definition of Clostridioides difficile PCR Ribotypes on the Basis of Whole Genome Polymorphisms: A Proof of Principle Study.

Authors:  Manisha Goyal; Lysiane Hauben; Hannes Pouseele; Magali Jaillard; Katrien De Bruyne; Alex van Belkum; Richard Goering
Journal:  Diagnostics (Basel)       Date:  2020-12-12

Review 4.  Role of microbiota and innate immunity in recurrent Clostridium difficile infection.

Authors:  Stefano Bibbò; Loris Riccardo Lopetuso; Gianluca Ianiro; Teresa Di Rienzo; Antonio Gasbarrini; Giovanni Cammarota
Journal:  J Immunol Res       Date:  2014-06-05       Impact factor: 4.818

5.  Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.

Authors:  Alice Banz; Aude Lantz; Brigitte Riou; Agnès Foussadier; Mark Miller; Kerrie Davies; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.